Harvard Study Ties Lithium Loss to Alzheimer’s in Nearly 7 Million Americans
Updated
Updated · Psychology Today · May 27
Harvard Study Ties Lithium Loss to Alzheimer’s in Nearly 7 Million Americans
2 articles · Updated · Psychology Today · May 27
Summary
A 2025 Harvard Medical School study in Nature found lithium was the only measured mineral consistently linked to Alzheimer’s pathology in postmortem human brain tissue.
Lithium levels were significantly lower in people with mild cognitive impairment or early Alzheimer’s and often undetectable in advanced disease, pointing to depletion as an early event rather than a late consequence.
Animal experiments in the same research induced lithium deficiency and reproduced amyloid plaques, tau tangles, synaptic loss and cognitive decline; restoring low-dose lithium orotate reversed several of those changes.
Earlier clinical and population evidence supports the preventive case: one study cited 5% Alzheimer’s incidence in lithium-treated bipolar patients versus 33% in untreated peers, while Brazilian trials reported cognitive stabilization with low doses.
The report argues Alzheimer’s begins decades before symptoms and reframes trace lithium supplementation—often 1-10 mg daily—as a potential prevention strategy for a disease affecting nearly 7 million Americans.
Harvard's study hails lithium for Alzheimer’s, so why did recent human trials using the mineral show no significant benefit?
Is Alzheimer's caused not by aging, but by a simple mineral deficiency that has been overlooked for decades?
Lithium Orotate Emerges as Promising Alzheimer’s Treatment After 2025 Discovery of Brain Lithium Deficiency
Overview
In August 2025, a Harvard-led study published in Nature Neuroscience revealed that lithium deficiency plays a critical and previously unrecognized role in the progression of Alzheimer’s disease. This discovery was hailed as a game-changer, fundamentally altering our understanding of Alzheimer’s and opening new possibilities for treatment. The research found that people with Alzheimer’s have significantly reduced lithium levels in the prefrontal cortex, and this reduction is a key driver of disease progression. These findings suggest that restoring lithium levels could offer a promising new approach for preventing and treating Alzheimer’s disease.